SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015841
Filing Date
2020-08-14
Accepted
2020-08-14 16:11:38
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 605000
2 ex10-2.htm EX-10.2 256491
3 ex31-1.htm EX-31.1 11402
4 ex31-2.htm EX-31.2 11364
5 ex32-1.htm EX-32.1 8491
6 ex32-2.htm EX-32.2 8133
  Complete submission text file 0001493152-20-015841.txt   3165139

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ogen-20200630.xml EX-101.INS 356064
8 XBRL SCHEMA FILE ogen-20200630.xsd EX-101.SCH 47062
9 XBRL CALCULATION FILE ogen-20200630_cal.xml EX-101.CAL 40781
10 XBRL DEFINITION FILE ogen-20200630_def.xml EX-101.DEF 136598
11 XBRL LABEL FILE ogen-20200630_lab.xml EX-101.LAB 297896
12 XBRL PRESENTATION FILE ogen-20200630_pre.xml EX-101.PRE 214551
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 201105177
SIC: 2834 Pharmaceutical Preparations